Perioperative ketorolac increases post-tonsillectomy hemorrhage in adults but not children

Laryngoscope. 2014 Aug;124(8):1789-93. doi: 10.1002/lary.24555. Epub 2014 May 27.

Abstract

Objectives/hypothesis: To evaluate the risk of post-tonsillectomy hemorrhage associated with perioperative ketorolac use.

Study design: Systematic review and meta-analysis of primary articles reporting individual-level post-tonsillectomy hemorrhage rates in subjects receiving perioperative ketorolac and matched controls. Retrospective and prospective studies were both included.

Methods: PubMed search was performed for "[ketorolac OR toradol] AND tonsillectomy." Articles fulfilling inclusion criteria were subjected to meta-analysis to determine summary relative risk (RR).

Results: Adults are at five times increased risk for post-tonsillectomy hemorrhage with ketorolac use (RR: 5.64; 95% confidence interval [CI]: 2.08-15.27; P < .001). In contrast, children under 18 are not at statistically significantly increased risk (RR: 1.39; 95% CI: 0.84-2.30; P = .20). Both retrospective and prospective studies yield consistent findings. There is no association of RR with pre- or postoperative administration of ketorolac.

Conclusions: Ketorolac can be used safely in children, but is associated with a five-fold increased bleeding risk in adults.

Keywords: Tonsillectomy; hemorrhage; ketorolac; obstructive sleep apnea.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Adult
  • Age Factors
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Child
  • Humans
  • Ketorolac / adverse effects*
  • Ketorolac / therapeutic use
  • Pain, Postoperative / prevention & control
  • Perioperative Care
  • Postoperative Hemorrhage / chemically induced*
  • Risk Assessment
  • Tonsillectomy*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Ketorolac